Table 1.
Ref. | Type of stem cells | Expression of stem cell/progenitor immunophenotypes and genes |
Human | ||
Liu et al[35], 2016 | NP-MSCs | CD73+, CD90+, CD105+, Oct4+, Nanog+, Jagged+ and Notch1+, CD34-, CD45-,HLA-DR- |
Li et al[36], 2017 | NP-SCs | GD2+, Tie2+ |
Li et al[37], 2018 | NP-MSCs | CD73+, CD90+, CD105+, CD34-, CD45-, HLA-DR- |
Jia et al[38], 2017 | D-NP-MSCs/ND-NP-MSCs | CD73+, CD90+, CD105+, Oct4+ and Nanog+, CD34-, CD45-, HLA-DR- |
Wu et al[40], 2017 | NP-SCs/NPPCs | CD29+, CD44+, CD 73+, CD90+, CD105+, Oct4+ and Nanog+, CD11b-, CD14-, CD34-, CD45-, HLA-DR- |
Wang et al[41], 2016 | NP-SCs/AF-SCs/CEP-SCs | CD73+, CD90+, CD105+, CD19-, CD34-, CD45-, HLA-DR- |
Liang et al[42], 2018 | NP-MSCs | CD73+, CD90+, CD105+, Sox2+ and Oct4+, CD14-, CD19-, CD34-, HLA-DR- |
Daisuke et al[43], 2012 | NPPCs | Tie2+, GD2+ |
Chen et al[44], 2018 | NP-MSCs | CD73+, CD90+, CD105+, CD34-, HLA-DR- |
Quan et al[48], 2015 | NP-MSCs | CD29+, CD44+, CD105+, CD14-, CD34-, CD45-, HLA-DR- |
Liu et al[49], 2017 | AF-MSCs, NP-MSCs, CEP-MSCs | CD73+, CD90+, CD105+, CD34-, CD45-, HLA-DR- |
Blanco et al[27], 2010 | NP-MSCs | CD73+, CD90+, CD105+, CD106+, CD166+, CD19-, CD34-, CD45-, HLA-DR- |
Lazzarini et al[50], 2018 | NP-MSCs | CD13+, CD73+, CD90+, CD105+, CD11b-, CD14-, CD19-, CD45-, HLA-DR- |
Pereira et al[51], 2016 | CEP-MSCs | Not shown |
Qi et al[57], 2018 | NP-MSCs | CD24+, CD73+, CD90+, CD105+, CD29-, CD45- |
Rat | ||
Zhao et al[34], 2017 | NP-MSCs | CD73+, CD90+, CD105+, CD34-, CD45- |
Li et al[39], 2019 | NP-MSCs | CD44+, CD73+, CD90+, CD105+, Oct4+, Nanog+ and Sox2+, CD34-, HLA-DR- |
Li et al[45], 2013 | NP-MSCs | CD73+, CD90+, CD105+, CD34-, CD45- |
Wang et al[46], 2019 | NP-MSCs | CD73+, CD90+, CD105, Tie2+, CD34-, CD45- |
Nan et al[52], 2019 | NP-MSCs | CD73+, CD90+, CD105+, CD34-, CD45- |
Han et al[29], 2014 | NP-MSCs | CD73+, CD90+, CD105+, CD34-, CD45- |
Tao et al[28], 2013 | NP-MSCs | CD73+, CD90+, CD105+, Nanog+, Sox2+, Rex1+ and Oct4+, CD34-, CD45- |
Tao et al[53], 2015 | NP-MSCs | CD73+, CD90+, CD105+, CD34-, CD45- |
Liu et al[30], 2019 | N-NP-MSCs/D-NP-MSCs | CD73+, CD90+, CD105+, CD166+, Sox2+, Nanog+, Oct4+, LIF+, PCNA+ and C-KIT+, CD34-, CD45- |
Li et al[55], 2018 | NP-MSCs | CD73+, CD90+, CD105+, CD34-, CD45- |
Cheng et al[56], 2019 | NP-MSCs | CD29+, CD44+, CD90+, CD34-, CD45- |
Lin et al[58], 2017 | NP-MSCs/NPPCs | CD29+, CD44+, CD90+, Nanog+, Oct4+ and Sox2+, CD34-, CD45- |
Liu et al[68], 2019 | NP-MSCs | CD73+, CD90+, CD105+, Sox2+, Nanog+ and Oct4+, CD34-, CD45- |
Zhang et al[69], 2015 | NP-MSCs | CD44+, CD73+, CD90+, CD105+, Sox2+, Nanog+ and Oct4+, CD14-, CD34-, CD45-, HLA-DR- |
Dog | ||
Erwin et al[47], 2013 | NPPCs | Oct3/4+, Sox2+, CD133+, Nanog+ and Nestin+ |
Bovine | ||
Tekari et al[63], 2016 | NPPCs | Tie2+ |
Rabbit | ||
Jia et al[54], 2018 | NP-MSCs | CD29+, CD44+, CD166+, CD4-, CD8-, CD14- |
MSC: Mesenchymal stem cell; NP: Nucleus pulposus; AF: Annulus fibrosus; CEP: Cartilaginous endplates; NPPC: NP-derived progenitor cell.